Atlas Trials

A Pilot Study Using Placenta Derived Decidual Stromal Cells for Toxicity and Inflammation With Special Focus to the Allogeneic Hematopoietic Cell Transplantation Setting

Clinical trial NCT02175303 · UNKNOWN

Trial details

NCT number
NCT02175303
Sponsor
Karolinska Institutet
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Acute Lung InjuryDecidual Stromal CellsStem Cell TransplantationInflammation
Start date
2013-12-01
Primary completion
2017-12-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.